PNPLA8 anticorps
Aperçu rapide pour PNPLA8 anticorps (ABIN7466444)
Antigène
Voir toutes PNPLA8 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Réactivité croisée
- Humain
-
Purification
- Purified by antigen-affinity chromatography.
-
Immunogène
- Recombinant protein encompassing a sequence within the center region of human PNPLA8. The exact sequence is proprietary.
-
Isotype
- IgG
-
-
-
-
Indications d'application
- WB: 1:500-1:3000. Optimal dilutions/concentrations should be determined by the researcher. Not tested in other applications.
-
Commentaires
-
Positive Control: Jurkat
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.84 mg/mL
-
Buffer
- 0.1M Tris-Glycine ( pH 7), 20 % Glycerol, 0.01 % Thimerosal
-
Agent conservateur
- Thimerosal (Merthiolate)
-
Précaution d'utilisation
- This product contains Thimerosal (Merthiolate): a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4°C. For long-term storage, aliquot and store at -20°C or below. Avoid multiple freeze-thaw cycles.
-
-
- PNPLA8 (Patatin-Like phospholipase Domain Containing 8 (PNPLA8))
-
Autre désignation
- patatin like phospholipase domain containing 8
-
Sujet
- Patatin like phospholipase domain containing 8 , IPLA2-2 , IPLA2G , MMLA , PNPLA-gamma , iPLA2gamma,Phospholipase A2 catalyzes cleavage of fatty acids from phospholipids, thereby regulating membrane physical properties and the release of lipid second messengers and growth factors. Phospholipase A2 activity also modulates cellular growth programs, inflammation, and ion channel function (Mancuso et al., 2000 [PubMed 10744668]).[supplied by OMIM]
-
Poids moléculaire
- 88 kDa
-
ID gène
- 50640
-
UniProt
- Q9NP80
Antigène
-